6461 related articles for article (PubMed ID: 21076616)
1. RIG-I helicase-independent pathway in sendai virus-activated dendritic cells is critical for preventing lung metastasis of AT6.3 prostate cancer.
Kato T; Ueda Y; Kinoh H; Yoneyama Y; Matsunaga A; Komaru A; Harada Y; Suzuki H; Komiya A; Shibata S; Hasegawa M; Hayashi H; Ichikawa T; Yonemitsu Y
Neoplasia; 2010 Nov; 12(11):906-14. PubMed ID: 21076616
[TBL] [Abstract][Full Text] [Related]
2. Sustained and NK/CD4+ T cell-dependent efficient prevention of lung metastasis induced by dendritic cells harboring recombinant Sendai virus.
Komaru A; Ueda Y; Furuya A; Tanaka S; Yoshida K; Kato T; Kinoh H; Harada Y; Suzuki H; Inoue M; Hasegawa M; Ichikawa T; Yonemitsu Y
J Immunol; 2009 Oct; 183(7):4211-9. PubMed ID: 19734206
[TBL] [Abstract][Full Text] [Related]
3. Induction of efficient antitumor immunity using dendritic cells activated by recombinant Sendai virus and its modulation by exogenous IFN-beta gene.
Shibata S; Okano S; Yonemitsu Y; Onimaru M; Sata S; Nagata-Takeshita H; Inoue M; Zhu T; Hasegawa M; Moroi Y; Furue M; Sueishi K
J Immunol; 2006 Sep; 177(6):3564-76. PubMed ID: 16951315
[TBL] [Abstract][Full Text] [Related]
4. Complete elimination of established neuroblastoma by synergistic action of gamma-irradiation and DCs treated with rSeV expressing interferon-beta gene.
Tatsuta K; Tanaka S; Tajiri T; Shibata S; Komaru A; Ueda Y; Inoue M; Hasegawa M; Suita S; Sueishi K; Taguchi T; Yonemitsu Y
Gene Ther; 2009 Feb; 16(2):240-51. PubMed ID: 18987675
[TBL] [Abstract][Full Text] [Related]
5. Immunostimulatory virotherapy using recombinant Sendai virus as a new cancer therapeutic regimen.
Yonemitsu Y; Ueda Y; Kinoh H; Hasegawa M
Front Biosci; 2008 May; 13():4953-9. PubMed ID: 18508560
[TBL] [Abstract][Full Text] [Related]
6. Development of immunostimulatory virotherapy using non-transmissible Sendai virus-activated dendritic cells.
Yoneyama Y; Ueda Y; Akutsu Y; Matsunaga A; Shimada H; Kato T; Kubota-Akizawa M; Okano S; Shibata S; Sueishi K; Hasegawa M; Ochiai T; Yonemitsu Y
Biochem Biophys Res Commun; 2007 Mar; 355(1):129-35. PubMed ID: 17292867
[TBL] [Abstract][Full Text] [Related]
7. Immunostimulatory virotherapy using recombinant Sendai virus as a new cancer therapeutic regimen.
Yonemitsu Y; Ueda Y; Kinoh H; Hasegawa M
Front Biosci; 2008 Jan; 13():1892-8. PubMed ID: 17981677
[TBL] [Abstract][Full Text] [Related]
8. Newly-developed Sendai virus vector for retinal gene transfer: reduction of innate immune response via deletion of all envelope-related genes.
Murakami Y; Ikeda Y; Yonemitsu Y; Tanaka S; Kondo H; Okano S; Kohno R; Miyazaki M; Inoue M; Hasegawa M; Ishibashi T; Sueishi K
J Gene Med; 2008 Feb; 10(2):165-76. PubMed ID: 18074401
[TBL] [Abstract][Full Text] [Related]
9. Tumor protection following vaccination with low doses of lentivirally transduced DCs expressing the self-antigen erbB2.
Mossoba ME; Walia JS; Rasaiah VI; Buxhoeveden N; Head R; Ying C; Foley JE; Bramson JL; Fowler DH; Medin JA
Mol Ther; 2008 Mar; 16(3):607-17. PubMed ID: 18180774
[TBL] [Abstract][Full Text] [Related]
10. Enhanced tumor-specific long-term immunity of hemagglutinating [correction of hemaggluttinating] virus of Japan-mediated dendritic cell-tumor fused cell vaccination by coadministration with CpG oligodeoxynucleotides.
Hiraoka K; Yamamoto S; Otsuru S; Nakai S; Tamai K; Morishita R; Ogihara T; Kaneda Y
J Immunol; 2004 Oct; 173(7):4297-307. PubMed ID: 15383558
[TBL] [Abstract][Full Text] [Related]
11. [New technologies for immunotherapy against cancer: development of cell expansion technology and viruses as immune boosters].
Harada Y; Yonemitsu Y
Yakugaku Zasshi; 2010 Nov; 130(11):1519-26. PubMed ID: 21048412
[TBL] [Abstract][Full Text] [Related]
12. Dramatic improvement of DC-based immunotherapy against various malignancies.
Harada Y; Yonemitsu Y
Front Biosci (Landmark Ed); 2011 Jun; 16(6):2233-42. PubMed ID: 21622173
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases.
Specht JM; Wang G; Do MT; Lam JS; Royal RE; Reeves ME; Rosenberg SA; Hwu P
J Exp Med; 1997 Oct; 186(8):1213-21. PubMed ID: 9334360
[TBL] [Abstract][Full Text] [Related]
14. Antagonism of VEGF by genetically engineered dendritic cells is essential to induce antitumor immunity against malignant ascites.
Sugiyama M; Kakeji Y; Tsujitani S; Harada Y; Onimaru M; Yoshida K; Tanaka S; Emi Y; Morita M; Morodomi Y; Hasegawa M; Maehara Y; Yonemitsu Y
Mol Cancer Ther; 2011 Mar; 10(3):540-9. PubMed ID: 21209070
[TBL] [Abstract][Full Text] [Related]
15. Route of administration influences the antitumor effects of bone marrow-derived dendritic cells engineered to produce interleukin-12 in a metastatic mouse prostate cancer model.
Saika T; Satoh T; Kusaka N; Ebara S; Mouraviev VB; Timme TL; Thompson TC
Cancer Gene Ther; 2004 May; 11(5):317-24. PubMed ID: 15044961
[TBL] [Abstract][Full Text] [Related]
16. Activated natural killer cell-mediated immunity is required for the inhibition of tumor metastasis by dendritic cell vaccination.
Kim A; Noh YW; Kim KD; Jang YS; Choe YK; Lim JS
Exp Mol Med; 2004 Oct; 36(5):428-43. PubMed ID: 15557815
[TBL] [Abstract][Full Text] [Related]
17. Highly immunostimulatory RNA derived from a Sendai virus defective viral genome.
Mercado-López X; Cotter CR; Kim WK; Sun Y; Muñoz L; Tapia K; López CB
Vaccine; 2013 Nov; 31(48):5713-21. PubMed ID: 24099876
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity.
Song W; Kong HL; Carpenter H; Torii H; Granstein R; Rafii S; Moore MA; Crystal RG
J Exp Med; 1997 Oct; 186(8):1247-56. PubMed ID: 9334364
[TBL] [Abstract][Full Text] [Related]
19. TRAIL and Noxa are selectively upregulated in prostate cancer cells downstream of the RIG-I/MAVS signaling pathway by nonreplicating Sendai virus particles.
Matsushima-Miyagi T; Hatano K; Nomura M; Li-Wen L; Nishikawa T; Saga K; Shimbo T; Kaneda Y
Clin Cancer Res; 2012 Nov; 18(22):6271-83. PubMed ID: 23014529
[TBL] [Abstract][Full Text] [Related]
20. Impact of deletion of envelope-related genes of recombinant Sendai viruses on immune responses following pulmonary gene transfer of neonatal mice.
Tanaka S; Yonemitsu Y; Yoshida K; Okano S; Kondo H; Inoue M; Hasegawa M; Masumoto K; Suita S; Taguchi T; Sueishi K
Gene Ther; 2007 Jul; 14(13):1017-28. PubMed ID: 17460720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
